Trade and investment liberalization and Asia’s noncommunicable disease epidemic: a synthesis of data and existing literature

Abstract

BackgroundTrade and investment liberalization (trade liberalization) can promote or harm health. Undoubtedly it has contributed, although unevenly, to Asia’s social and economic development over recent decades with resultant gains in life expectancy and living standards. In the absence of public health protections, however, it is also a significant upstream driver of non-communicable diseases (NCDs) including cardiovascular disease, cancer and diabetes through facilitating increased consumption of the ‘risk commodities’ tobacco, alcohol and ultra-processed foods, and by constraining access to NCD medicines. In this paper we describe the NCD burden in Asian countries, trends in risk commodity consumption and the processes by which trade liberalization has occurred in the region and contributed to these trends. We further establish pressing questions for future research on strengthening regulatory capacity to address trade liberalization impacts on risk commodity consumption and health.MethodsA semi-structured search of scholarly databases, institutional websites and internet sources for academic and grey literature. Data for descriptive statistics were sourced from Euromonitor International, the World Bank, the World Health Organization, and the World Trade Organization.ResultsConsumption of tobacco, alcohol and ultra-processed foods was prevalent in the region and increasing in many countries. We find that trade liberalization can facilitate increased trade in goods, services and investments in ways that can promote risk commodity consumption, as well as constrain the available resources and capacities of governments to enact policies and programmes to mitigate such consumption. Intellectual property provisions of trade agreements may also constrain access to NCD medicines. Successive layers of the evolving global and regional trade regimes including structural adjustment, multilateral trade agreements, and preferential trade agreements have enabled transnational corporations that manufacture, market and distribute risk commodities to increasingly penetrate and promote consumption in Asian markets.ConclusionsTrade liberalization is a significant driver of the NCD epidemic in Asia. Increased participation in trade agreements requires countries to strengthen regulatory capacity to ensure adequate protections for public health. How best to achieve this through multilateral, regional and unilateral actions is a pressing question for ongoing research.

Global trends and patterns of commercial milk-based formula sales: is an unprecedented infant and young child feeding transition underway?

“…In 2014, the Chinese MF market alone was worth $US 17·8 billion (12) . With stagnating growth in the more heavily regulated high-income markets, developing Asian countries are seen as new growth opportunities given their rising income levels, young and growing populations, and openness to foreign investment (49) . Additionally, TMFC often donate large quantities of MF to countries in post-disaster situations, potentially undermining breast-feeding in this context.…”

“…Just 330 million (28·4 %) are legally entitled to receive cash payments in the event of childbirth (61) . Free trade agreements, which have been extensive in East Asia in recent decades, reduce barriers to the movement of investments, production capacity, raw materials and final products across borders (49) . These processes enable TMFC to more easily expand their operations through the establishment of transnational networks of affiliate firms and highly coordinated global supply chains (62) .…”

Trade and investment liberalization and Asia¿s noncommunicable disease epidemic: a synthesis of data and existing literature

“…In a world characterised by increasing economic globalization it is important to understand how markets and commercial actors operate in ways that are detrimental or beneficial to health [154]. This article has demonstrated how the evolving layers of the international and regional trade regimes have facilitated increased market penetration by transnational tobacco, alcohol and ultra-processed food corporations and thereby driven consumption of these risk commodities in Asia.…”

The Trans-Pacific Partnership: Is It Everything We Feared for Health?

“…A body of literature exploring the relationships between international trade and investment agreements and health has been accruing over the past few years. [4][5][6][7][8][9][10][11][12] But with the exception of one of those studies, 11 the literature to date has largely been conceptual in nature, and has rarely explored specific treaty text.…”

“…Most of the environmental disputes, over water, land-use, pollution control and hazardous waste, have important indirect health implications. The high costs of defending against a dispute [4] , and the difficulty in knowing how a tribunal will rule in a case, are thought to contribute to 'regulatory chill, ' in which governments become more reluctant to enact new policy for fear of being sued. 37 The current system for ISDS has been criticised for continuing to lack a coordinating body, a mechanism for political oversight, rules on transparency, and legal processes to correct incorrect decisions.…”